Neuland Laboratories Executive and Leadership Team

Saharsh Davuluri, the Chief Executive Officer & Managing Director at Neuland Laboratories, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of advanced process chemistry with cGMP manufacturing, Davuluri ensures the company maintains a competitive edge within the global pharmaceutical landscape. This leadership role involves constant collaboration with the Board to align operational output with international regulatory requirements. By prioritizing innovation in API development, the Chief Executive Officer & Managing Director drives sustainable growth across all manufacturing facilities. Saharsh Davuluri also manages the expansion of chemistry-related services, ensuring that the firm remains a preferred partner for drug development. Through meticulous oversight of technical teams, the executive secures the company's position as a leader in the pharmaceutical industry, consistently delivering reliable solutions that meet the complex needs of global clients while upholding the highest standards of quality and operational excellence.

Abhijit Majumdar, the Chief Financial Officer at Neuland Laboratories, manages the fiscal health and capital allocation strategies required to sustain large-scale API manufacturing operations. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures that the company maintains the liquidity necessary for continuous investment in process chemistry research. This leadership role involves coordinating with the executive team to evaluate the financial viability of new drug development projects and global market expansion efforts. By optimizing cost structures and monitoring capital expenditures, Abhijit Majumdar supports the firm's long-term profitability goals. The Chief Financial Officer also maintains transparent communication with stakeholders regarding the company's economic performance and growth trajectory. Through rigorous financial oversight, the executive secures the resources needed to uphold cGMP standards across all facilities. Majumdar drives fiscal discipline, ensuring that the organization remains financially resilient while pursuing its mission to provide high-quality pharmaceutical solutions to the global market.

Shashank Mahashabde, the Contract Manufacturing President, Business Development at Neuland Laboratories, directs the expansion of the company's contract manufacturing services for global pharmaceutical clients. Overseeing the acquisition of new partnerships, the Contract Manufacturing President, Business Development ensures that the firm's process chemistry expertise is effectively leveraged to meet the specific needs of external drug developers. This role involves negotiating complex service agreements and managing the transition of projects from development to full-scale cGMP manufacturing. By identifying growth opportunities in international markets, Shashank Mahashabde drives the company's commercial success. The Contract Manufacturing President, Business Development also collaborates with technical teams to ensure that client requirements are met with precision and reliability. Through the strategic management of business relationships, the executive secures long-term contracts that support the firm's mission. Mahashabde focuses on delivering end-to-end solutions that accelerate the drug development process for partners worldwide, maintaining the company's reputation for excellence.

Ajitabh Singh, the Chief Information Officer at Neuland Laboratories, architects the digital infrastructure necessary to support complex pharmaceutical manufacturing processes. Managing the secure integration of data across all production sites, the Chief Information Officer ensures that information systems remain compliant with global regulatory standards. This role involves deploying advanced analytics to optimize supply chain visibility and manufacturing efficiency. By modernizing the technological framework, Ajitabh Singh enables seamless communication between research teams and global partners. The Chief Information Officer also oversees cybersecurity initiatives to protect proprietary chemistry data and intellectual property. Through the implementation of robust digital platforms, the executive supports the company's mission to accelerate drug development. Singh maintains a focus on scalable technology solutions that facilitate real-time monitoring of production cycles, ultimately driving operational agility and ensuring that the firm remains at the forefront of digital transformation within the highly regulated pharmaceutical manufacturing sector.

Hemchandra Peruvelli, the Chief Human Resources Officer at Neuland Laboratories, directs the talent acquisition and organizational development strategies essential for maintaining a highly skilled scientific workforce. Overseeing the recruitment of experts in process chemistry and regulatory compliance, the Chief Human Resources Officer ensures that the company attracts top-tier talent to support its complex manufacturing operations. This role involves designing performance management systems that align individual contributions with the firm's overarching mission of accelerating drug development. By fostering a culture of safety and technical excellence, Hemchandra Peruvelli promotes employee engagement across all regional operations. The Chief Human Resources Officer also manages leadership development programs to prepare the next generation of pharmaceutical professionals. Through the implementation of robust human capital policies, the executive supports the company's ability to meet the evolving demands of the global pharmaceutical industry. Peruvelli ensures that the workforce remains equipped to handle the rigorous requirements of cGMP manufacturing environments.

Raja Shekar, the Deputy Manager, Material Planning & Chief Marketing Officer at Neuland Laboratories, manages the intersection of supply chain logistics and market positioning for the company's API portfolio. Overseeing material planning, the Deputy Manager, Material Planning & Chief Marketing Officer ensures that production schedules align with the availability of raw materials required for complex chemistry services. Simultaneously, the executive directs marketing initiatives to promote the firm's capabilities to global pharmaceutical partners. This dual role involves analyzing market trends to identify new opportunities for drug development services. By coordinating with manufacturing teams, Raja Shekar ensures that the company meets client demand while maintaining efficient inventory levels. The Deputy Manager, Material Planning & Chief Marketing Officer also develops strategies to enhance the brand's visibility in international markets. Through the integration of supply chain data and market insights, the executive drives revenue growth and ensures that the firm remains a reliable provider of high-quality pharmaceutical ingredients.

Adrian Monk, the Chief Medical Officer at Neuland Laboratories, provides clinical oversight and scientific guidance for the company's drug development and API manufacturing initiatives. Overseeing the medical integrity of the firm's chemistry-related services, the Chief Medical Officer ensures that all products meet the stringent safety and efficacy standards required by global regulatory bodies. This role involves collaborating with research teams to validate the clinical relevance of new pharmaceutical compounds. By monitoring emerging medical trends, Adrian Monk helps the company align its manufacturing capabilities with the future needs of the healthcare industry. The Chief Medical Officer also serves as a liaison between the firm and clinical partners, ensuring that technical solutions directly address patient health outcomes. Through rigorous scientific review, the executive supports the company's mission to facilitate the development of life-saving medications. Monk maintains a focus on quality assurance, ensuring that every API produced adheres to the highest medical and regulatory benchmarks.

Dorothy Paul, the Chief Marketing & Communications Officer at Neuland Laboratories, directs the global brand strategy and corporate communications for the organization. Overseeing the messaging that highlights the company's expertise in process chemistry and API manufacturing, the Chief Marketing & Communications Officer ensures that the firm's value proposition is clearly articulated to the global pharmaceutical industry. This role involves managing public relations, digital presence, and stakeholder engagement to build trust with partners and investors. By crafting narratives that emphasize the company's 25-year history of facilitating drug development, Dorothy Paul strengthens the firm's market position. The Chief Marketing & Communications Officer also coordinates internal communications to ensure alignment with the company's mission and values. Through the implementation of targeted marketing campaigns, the executive drives awareness of the firm's end-to-end solutions. Paul maintains a focus on consistent brand messaging, ensuring that the organization remains a recognized leader in the competitive pharmaceutical manufacturing sector.